| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6120774 | Journal of Clinical Virology | 2013 | 7 Pages |
Abstract
Applying combined HBsAg and HBV-DNA cutoffs to baseline measurements accurately differentiated RPs. These results suggest that HBsAg should be included in the monitoring of asymptomatic HBeAg(â) CHB patients.
Keywords
IFNL3Inactive carrierBCPCHBHBsAgHBeAgPPVALTHBV-DNAHCCAlanine aminotransferaseHepatitis B surface antigenpositive predictive valuenegative predictive valueinterferonIFNprecoreNPV یا negative predictive valueHepatitis B e antigenchronic hepatitis BHBVViral hepatitishepatitis B virusBasal core promoterprognosisHepatocellular carcinoma
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Michelle Martinot-Peignoux, Martine Lapalus, Cédric Laouénan, Olivier Lada, Ana Carolina Ferreira Netto-Cardoso, Nathalie Boyer, Marie Pierre Ripault, Roberto Carvalho-Filho, Tarik Asselah, Patrick Marcellin,